No abstract

No abstract

Background: Metal-organic frameworks (MOFs), as attractive hybrid crystalline porous materials, are increasingly being investigated in biomedical applications owing to their exceptional properties, including high porosity, ultrahigh surface areas, tailorable composition and structure, and tunability and surface functionality. Of interest in this review is the design and development of MOFbased drug delivery systems (DDSs) that have excellent biocompatibility, good stability under physiological conditions, high drug loading capacity, and controlled/targeted drug release. Objective: This review highlights the latest advances in MOFs as anticancer drug delivery systems (DDSs) along with insights on their design, fabrication, and performance under different stimuli that are either internal or external. The synthesis methods of MOFs, along with their advantages and disadvantages, are briefly discussed. The emergence of multifunctional MOF-based theranostic platforms is also discussed. Finally, the future challenges facing the developments of MOFs in the field of drug delivery are discussed. Methods: The review was prepared by carrying out a comprehensive literature survey using relevant work published in various scientific databases. Results: Novel MOFs in biomedical applications, especially in drug delivery, have shown great potentials. MOF-based DDSs can be classified into normal (non-controllable) DDSs, stimuli-responsive DDSs, and theranostic platforms. The normal DDSs are pristine MOFs loaded with MOFs and offer little to no control over the drug delivery. Stimuli-responsive DDSs offer better spatiotemporal control over the drug release by responding to either endogenous (pH, redox, ions, ATP) or exogenous stimuli (light, magnetism, US, pressure, temperature). The theranostic platforms combine stimuli-responsive drug delivery with diagnostic imaging functionality, paving the road for imaging-guided drug delivery. Conclusion: This review presented a summary of the various methods utilized in MOF synthesis along with the advantages and disadvantages of each method. Furthermore, the review highlighted and discussed the latest developments in the field of MOF-based DDSs and theranostic platforms. The review is focused on the characteristics of MOF-based DDSs, the encapsulation of different anticancer drugs as well as their stimuli-responsive release.

No abstract

In the present work, continuous ixed-bed column and batch studies were undertaken to investigate the eiciency of ironbased metal-organic framework (Fe-BTC) for the removal of methyl orange as a model contaminant from aqueous solutions. The batch experiments were carried out by varying operational parameters such as adsorbent dosage, pH, temperature, and initial contaminant concentration. The results showed that Fe-BTC had a high removal eiciency under a wide pH range. The equilibrium data were best itted by the Langmuir model with a maximum adsorption capacity of 100.3 mg g −1 at 298 K. In order to assess the industrial feasibility of Fe-BTC, ixed-bed column studies were conducted to obtain breakthrough curves, breakthrough and saturation times, and maximum uptakes at diferent bed heights. The breakthrough time was 20.0 and 46.2 h at 0.75 and 1.5 cm bed depths, respectively. The bed removal eiciency was 35.2 and 46.7% at 0.75 and 1.5 cm bed depth, respectively. The bed maximum adsorption capacity was 20.2 and 21.6 mg/g at 0.75 and 1.5 cm bed depths, respectively. Moreover, the application of empirical breakthrough curve models showed good agreement with the modiied dose response model (R 2 > 0.99). Also, the analytical solution of the advection-dispersion-adsorption mass transfer equation showed an excellent it to the experimental breakthrough data (R 2 > 0.99). Further, the analytical model was utilized to predict the length of the mass transfer zone as a function of the bed depth and to construct a 3D surface plot that can be utilized to predict the breakthrough at diferent bed depths.